View of Pembrolizumab: metastatic melanoma therapeutic option at the Integrated Health Organization Barrualde-Galdakao | Osagaiz: osasun-zientzien aldizkaria

← Pembrolizumab: metastatic melanoma therapeutic option at the Integrated Health Organization Barrualde-Galdakao